Sage Therapeutics Inc
SAGE
ISIN null / Valor 24747713
Sage Therapeutics Inc
UMushroom community rating:
About company
Sage Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative medicines to treat brain health disorders. The company has made significant strides in addressing maternal mental health by bringing to market the only FDA-approved treatments for postpartum depression. Beyond maternal mental health, Sage Therapeutics is also working on pioneering treatments for other brain health issues, including essential tremor and cognitive impairment associated with neurodegenerative diseases. By integrating patient and care partner perspectives throughout the research and commercialization processes, Sage aims to meet the unmet needs within the realm of brain health disorders, striving to make a meaningful impact on millions of lives by viewing and treating brain health through a new lens.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
545 M
Market cap (USD)
Daily traded volume (Shares)
5.475 / 5.255
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
